![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/7125 | |
A61K 31/713 | |||
A61P 35/00 | |||
A61P 35/04 |
(11) | Number of the document | 3302502 |
(13) | Kind of document | T |
(96) | European patent application number | 16727089.1 |
Date of filing the European patent application | 2016-05-23 | |
(97) | Date of publication of the European application | 2018-04-11 |
(45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/033817 |
Date | 2016-05-23 |
(87) | Number | WO 2016/196062 |
Date | 2016-12-08 |
(30) | Number | Date | Country code |
201562168449 P | 2015-05-29 | US | |
201562168470 P | 2015-05-29 | US | |
201562169309 P | 2015-06-01 | US | |
201562169321 P | 2015-06-01 | US | |
201662276767 P | 2016-01-08 | US |
(72) |
GUIDUCCI, Cristiana, US
COFFMAN, Robert L., US
|
(73) |
Dynavax Technologies Corporation,
2929 Seventh Street, Suite 100, Berkeley, CA 94710,
US
|
(54) | INTRAPULMONARY ADMINISTRATION OF POLYNUCLEOTIDE TOLL-LIKE RECEPTOR 9 AGONISTS FOR TREATING CANCER OF THE LUNG |
INTRAPULMONARY ADMINISTRATION OF POLYNUCLEOTIDE TOLL-LIKE RECEPTOR 9 AGONISTS FOR TREATING CANCER OF THE LUNG |